Retevmo Granted Traditional Approval for RET Fusion-Positive Thyroid Cancer

Retrieved on: 2024-06-16 18:08:44

Tags for this article:

Click the tags to see associated articles and topics

Retevmo Granted Traditional Approval for RET Fusion-Positive Thyroid Cancer. View article details on hiswai:

Excerpt

The US Food and Drug Administration (FDA) has granted traditional approval to Retevmo (selpercatinib) to treat patients 2 years of age and older ...

Article found on: www.cancertherapyadvisor.com